Drug-induced lupus: clinical and serological studies.
D000123:Acetyltransferases / Q000235:genetics; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis*; D000927:Anticonvulsants / Q000009:adverse effects; D001168:Arthritis / Q000209:etiology; D002746:Chlorpromazine / Q000009:adverse effects; D003429:Cross Reactions; D005260:Female; D005802:Genes, MHC Class II; D006684:HLA-DR Antigens; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D007538:Isoniazid / Q000009:adverse effects; D007592:Joint Diseases / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D010996:Pleural Effusion / Q000209:etiology; D010998:Pleurisy / Q000150:complications; D011342:Procainamide / Q000009:adverse effects; D013601:T-Lymphocytes / Q000187:drug effects
D000974:Antibodies, Antinuclear; D000927:Anticonvulsants; D006684:HLA-DR Antigens; D006830:Hydralazine; D000123:Acetyltransferases; D011342:Procainamide; D002746:Chlorpromazine; D007538:Isoniazid